Area of research
Internal Medicine · Cardiology and Cardiovascular Medicine
Research interest
Research interests include Venous Thromboembolism Diagnosis and Management, Atrial Fibrillation Management and Outcomes, Central Venous Catheters and Hemodialysis, and Diagnosis and Treatment of Venous Diseases.
Evidence-based risk stratification of patients with acute pulmonary embolism: communication from the ISTH SSC Subcommittee on Predictive and Diagnostic Variables in Thrombotic Disease
2023 ACR/EULAR antiphospholipid syndrome classification criteria
Use of patient-reported outcome measures in patients with venous thromboembolism: communication from the ISTH SSC Subcommittee on Predictive and Diagnostic Variables in Thrombotic Disease
DOAC compared with warfarin for VTE in patients with obesity: a retrospective cohort study conducted through the VENUS network
Antithrombotic management of patients with deep vein thrombosis and venous stents: an international registry
Direct Oral Anticoagulants vs Vitamin K Antagonists in Patients With Antiphospholipid Syndromes
Management of bleeding risk in patients who receive anticoagulant therapy for venous thromboembolism: Communication from the ISTH SSC Subcommittee on Predictive and Diagnostic Variables in Thrombotic Disease
Impact of anticoagulation therapy on the cognitive decline and dementia in patients with non‐valvular atrial fibrillation (cognitive decline and dementia in patients with non‐valvular atrial fibrillation [<scp>CAF</scp>] trial)
Antithrombotic Therapy for VTE Disease
Apixaban compared with warfarin to prevent thrombosis in thrombotic antiphospholipid syndrome: a randomized trial
Natural Language Processing Performance for the Identification of Venous Thromboembolism in an Integrated Healthcare System
16th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends
Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: Guidance from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis
Prognostic factors for VTE and bleeding in hospitalized medical patients: a systematic review and meta-analysis
Cost-effectiveness of managing low-risk pulmonary embolism patients without hospitalization. The low-risk pulmonary embolism prospective management study
Risk models for VTE and bleeding in medical inpatients: systematic identification and expert assessment
Rationale and design of the impact of anticoagulation therapy on the Cognitive Decline and Dementia in Patients with Nonvalvular Atrial Fibrillation (CAF) Trial: A Vanguard study
Management of Low-Risk Pulmonary Embolism Patients Without Hospitalization
Weight-based enoxaparin dosing and deep vein thrombosis in hospitalized trauma patients: A double-blind, randomized, pilot study
Effect of Genotype-Guided Warfarin Dosing on Clinical Events and Anticoagulation Control Among Patients Undergoing Hip or Knee Arthroplasty
Protocol Modification of Apixaban for the Secondary Prevention of Thrombosis Among Patients With Antiphospholipid Syndrome Study
15th International Congress on Antiphospholipid Antibodies Task Force on Antiphospholipid Syndrome Treatment Trends Report
Patterns and Appropriateness of Thrombophilia Testing in an Academic Medical Center
Preemptive Anticoagulation in Patients With a High Pretest Probability of Pulmonary Embolism
Antithrombotic Therapy for VTE Disease
Guidance for the evaluation and treatment of hereditary and acquired thrombophilia
The Michigan Appropriateness Guide for Intravenous Catheters (MAGIC): Results From a Multispecialty Panel Using the RAND/UCLA Appropriateness Method
Apixaban for the Secondary Prevention of Thrombosis Among Patients With Antiphospholipid Syndrome
The Association Between PICC Use and Venous Thromboembolism in Upper and Lower Extremities